Massachusetts Investigates $1,000 Cost Of Gilead Hepatitis C Pill
The Massachusetts attorney general's office said Wednesday that it is investigating whether the Bay Area makers of a breakthrough treatment for hepatitis C are violating state law by pricing the drugs too high.